Skip to content

Clinical trials

Observational Pulmonary Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Observational Clear all

359 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20044
20056
20068
20078
20089
20099
20108
201115
201215
201311
201418
201522
201618
201716
201824
201920
202029
202121
202215
202314
202422
202514
202621

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed190
Unknown status77
Recruiting45
Not yet recruiting13
Withdrawn11
Terminated11
Active, not recruiting8
Enrolling by invitation2
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Brigham and Women's Hospital15
Bayer9
University Hospital, Brest9
Assiut University8
Ottawa Hospital Research Institute7
University Hospital, Strasbourg, France7
Centre Hospitalier Universitaire de Saint Etienne6
China-Japan Friendship Hospital5
Peking Union Medical College Hospital5
Azienda Ospedaliero-Universitaria Careggi4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism359
Venous Thrombosis122
Venous Thromboembolism76
Thrombosis33
Atrial Fibrillation21
COVID-1919
Disease17
Thromboembolism16
Neoplasms14
Stroke14

Trials

Showing 51 to 75 of 359. Each trial links to its page on Pharma Observatory.

259 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.